Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Cashing in credit card points at the right time can yield maximum value. Learn the best strategies for optimizing your rewards.
25,223 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Markets bounce and retreat. This guide explains why here's buying bitcoin right can fit into a balanced, long-term in...
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Zcash climbs above $470 as investors react to news of the Ironwood upgrade slated for late July. The changes aim to m...
A writer and friend test a cold plunge before a work-from-home day, reporting a sharper, calmer morning. The piece ex...
A pregnant caller who paid off $80,000 in debt on a tight timeline sparks debate over financial strategy and the role...
The U.S. IPO market is rekindling activity in 2026, with more offerings and steadier early trading as investors weigh...
The SEC on June 11, 2026 proposed scrapping a 20-year-old rule that tied stock trading to NBBO quotes, a move that co...
Crypto markets surged as talk of a potential Iran truce revived risk appetite. Ripple and Ethereum led gains, with Bi...
Two defense-focused ETFs offer distinct paths to play defense spending. This guide compares SHLD and ITA on cost, hol...
Late-career savers confront a split reality: high earners push the average higher, while the typical balance for many...
A private Founders Table dinner in New York drew senior leaders from crypto, AI and traditional finance during ETHCon...